Effects of sympathetic modulation in metabolic disease-Reference-Cited by-同舟云学术

Effects of sympathetic modulation in metabolic disease

Published:2019-08-19 Issue:1 Volume:1454 Page:80-89
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Carnagarin Revathy¹,Lambert Gavin W.²³,Kiuchi Marcio G.¹,Nolde Janis M.¹,Matthews Vance B.¹,Eikelis Nina²³,Lambert Elisabeth A.²³,Schlaich Markus P.¹⁴⁵

Affiliation:

1. Dobney Hypertension Centre, School of Medicine – Royal Perth Hospital Unit/Medical Research FoundationUniversity of Western Australia Perth Western Australia Australia

2. Iverson Health Innovation Research InstituteSwinburne University of Technology Hawthorn Victoria Australia

3. School of Health SciencesSwinburne University of Technology Hawthorn Victoria Australia

4. Departments of Cardiology and NephrologyRoyal Perth Hospital Perth Western Australia Australia

5. Neurovascular Hypertension and Kidney Disease LaboratoryBaker Heart and Diabetes Institute Melbourne Victoria Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.14217

Reference98 articles.

1. Neural control of renal function

2. The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension

3. The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension

4. Sympathetic nervous activation in obesity and the metabolic syndrome—Causes, consequences and therapeutic implications

5. Autonomic impairment in rheumatoid arthritis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement;Journal of Hypertension;2024-05-15

2. Pyridostigmine attenuated high‐fat‐diet induced liver injury by the reduction of mitochondrial damage and oxidative stress via α7nAChR and M3AChR;Journal of Biochemical and Molecular Toxicology;2024-03

3. Sympathetic circuits regulating hepatic glucose metabolism: where we stand;Physiological Reviews;2024-01-01

4. 12,13-diHOME and noradrenaline are associated with the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2023-06-29

5. A critical review on brain and heart axis response in COVID‐19 patients: Molecular mechanisms, mediators, biomarkers, and therapeutics;Journal of Biochemical and Molecular Toxicology;2023-06-21